MAPT Antikörper (AA 171-266)
Kurzübersicht für MAPT Antikörper (AA 171-266) (ABIN1833880)
Target
Alle MAPT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 171-266
-
Spezifität
- Human TAU
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to a region within amino acids 171 and 266 of Tau (SwissProt P10636).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ICC, IF, WB
Usage: Antibody reactive against peptide, detects immunogen. Further validation in progress. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.0, 20 % glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Keep as concentrated solution. Avoid multiple freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Andere Bezeichnung
- MAPT / tau
-
Hintergrund
-
Name/Gene ID: MAPT
Synonyms: MAPT, FTDP-17, MSTD, Neurofibrillary tangle protein, PHF-tau, MTBT2, PPND, DDPAC, MAPTL, MTBT1, Paired helical filament-tau, TAU -
Gen-ID
- 4137
-
UniProt
- P10636
-
Pathways
- MAPK Signalweg, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-